PowerLoc MAX Power-Injectable Infusion Set myPICK Port Access Kit; Catalog Numbers CPA00001 (UDI 00801741098345), CPA00002 (UDI 00801741098352), CPA00028 (UDI 00801741129728), CPA00032 (UDI 00801741137501), CPA00033 (UDI 00801741137501), CPA00036 (UDI 00801741138911), CPA00051 (UDI 00801741175718), CPA00055 UDI 00801741182181), CPA00056 (UDI 00801741182907)
Published July 29, 2020 · Recall initiated: June 19, 2020
Summary
FDA records medical device Class II recall Z-2661-2020, published July 29, 2020 and initiated June 19, 2020. Recalling firm: Becton Dickinson & Company; Status: Terminated; Reported quantity: 5,296,132 total; Lot: Catalog Numbers CPA00001 (UDI 00801741098345), CPA00002 (UDI 00801741098352), CPA00028 (UDI 00801741129728), CPA00032 (UDI 00801741137501), CPA00033 (UDI 00801741137501), CPA00036 (UDI 00801741138911), CPA00051 (UDI 00801741175718), CPA00055 UDI 00801741182181), CPA00056 (UDI 00801741182907). Lot Numbers: REEN0212 REEP2685 REEP3660 REEQ3563 REER1968 REDZ0705 REEP3313 REEP3547 REER0577 REEN0214 REEQ3569 REDY3552 REEN1934 REEP3280 REEP3552 REER1115 REEN0218 REEP3659 REEP1436 REER0298 REER1335 REDY0992 REEN0278 REEP1437 REEQ0232. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A crack or break could result in potential blood loss, catheter occlusion, air embolism, under or interrupted infusion, or site contamination which could lead to infection.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Becton Dickinson & Company
- Distributor
- Worldwide Distribution
- Lot
- Catalog Numbers CPA00001 (UDI 00801741098345), CPA00002 (UDI 00801741098352), CPA00028 (UDI 00801741129728), CPA00032 (UDI 00801741137501), CPA00033 (UDI 00801741137501), CPA00036 (UDI 00801741138911), CPA00051 (UDI 00801741175718), CPA00055 UDI 00801741182181), CPA00056 (UDI 00801741182907). Lot Numbers: REEN0212 REEP2685 REEP3660 REEQ3563 REER1968 REDZ0705 REEP3313 REEP3547 REER0577 REEN0214 REEQ3569 REDY3552 REEN1934 REEP3280 REEP3552 REER1115 REEN0218 REEP3659 REEP1436 REER0298 REER1335 REDY0992 REEN0278 REEP1437 REEQ0232
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDABD®Spinal Tray with BD®Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) withJune 10, 2026
- FDABD®Spinal Tray with BD®Quincke Needle 26 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) withJune 10, 2026
- FDABD®Spinal Tray with BD®Whitacre Needle 22 G x 3.5 in.; lidocaine HCL (1%), 5 mL, bupivacaine HCL (0.75%) withJune 10, 2026
- FDABD®Spinal Tray with BD®Whitacre Needle 25 G x 3.5 in.; lidocaine HCL (1%), 2 mL, bupivacaine HCL (0.75%) withJune 10, 2026
- FDAPowerLoc MAX Power Injectable Infusion Set AllPoints Port Access System; Catalog Numbers AN132075 (UDIJuly 29, 2020
- FDAPowerLoc MAX Power Injectable Infusion Port Access Kit; Catalog Numbers 2131910 (UDI 00801741044151), 2131915July 29, 2020
Questions about this recall
Was PowerLoc MAX Power-Injectable Infusion Set myPICK Port Access Kit; Catalog Numbers CPA00001 (UDI 00801741098345), CPA00002 (UDI 00801741098352), CPA00028 (UDI 00801741129728), CPA00032 (UDI 00801741137501), CPA00033 (UDI 00801741137501), CPA00036 (UDI 00801741138911), CPA00051 (UDI 00801741175718), CPA00055 UDI 00801741182181), CPA00056 (UDI 00801741182907) recalled?
Yes. FDA published recall Z-2661-2020 on July 29, 2020. Reported hazard: Potential development of cracks or breaks in the tubing near the Luer or Y site of the device. Devices that have developed breaks or cracks can cause leakage resulting in exposure to chemicals such a chemotherapeutics or biohazard material (e.g., blood). A crack or break could result in potential blood loss, catheter occlusion, air embolism, under or interrupted infusion, or site contamination which could lead to infection.
What should I do if I have this product?
Voluntary: Firm initiated · Letter